Back
BeiGene Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison
Sell
38
BGNE
BeiGene
Last Price:
153.16
Seasonality Move:
18.09%
Sell
45
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
34.39
Seasonality Move:
-9.19%
Sell
38
BeiGene (BGNE)
is a Sell
Is BeiGene a Buy, Sell or Hold?
- The current BeiGene [BGNE] share price is $153.58. The Score for BGNE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- BGNE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Corbus Pharmaceuticals Holdings (CRBP)
is a Sell
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $34.25. The Score for CRBP is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- CRBP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $34.25
The current trend is moderately bearish and CRBP is experiencing buying pressure, which is a positive indicator for future bullish movement.
BGNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.58 | Sell |
| Relative Strength Index (14 RSI): | 57.06 | Buy |
| Chaikin Money Flow: | 109352 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (137.45 - 155.13) | Buy |
| Bollinger Bands (100): | (146.66 - 175.92) | Sell |
CRBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.27 | Sell |
| Relative Strength Index (14 RSI): | 43.27 | Sell |
| Chaikin Money Flow: | 61510 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.63 - 40.09) | Sell |
| Bollinger Bands (100): | (9.33 - 38.21) | Buy |
BGNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 138.71 | Buy |
| 20-day SMA: | 144.32 | Buy |
| 50-day SMA: | 154.61 | Sell |
| 200-day SMA: | 176.23 | Sell |
| 8-day EMA: | 143.34 | Buy |
| 20-day EMA: | 144.96 | Buy |
| 50-day EMA: | 151.94 | Buy |
| 200-day EMA: | 173.44 | Sell |
CRBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.43 | Sell |
| 20-day SMA: | 38.25 | Sell |
| 50-day SMA: | 36.25 | Sell |
| 200-day SMA: | 14.94 | Buy |
| 8-day EMA: | 36.28 | Sell |
| 20-day EMA: | 37.41 | Sell |
| 50-day EMA: | 34.26 | Sell |
| 200-day EMA: | 19.79 | Buy |
BeiGene Earnings Growth & BGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.20 per share, and an increase next year of $4.67 per share.
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.69 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.66 per share, and an increase next year of $0.09 per share.
BeiGene Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Corbus Pharmaceuticals Holdings Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||